Error: Could not add to watchlist. X
+ Watchlist

Progenics Pharmaceuticals Inc

PGNX:US
NASDAQ GS
10.62
USD
0.08
0.76%
As of 8:10 PM EST 2/17/2017
Open
10.53
Day Range
10.33 - 10.84
Volume
13,149,855
Previous Close
10.54
52Wk Range
3.80 - 10.84
1 Yr Return
124.52%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
10.53
Day Range
10.33 - 10.84
Volume
13,149,855
Previous Close
10.54
52Wk Range
3.80 - 10.84
1 Yr Return
124.52%
YTD Return
22.92%
Current P/E Ratio (TTM)
61.92
Earnings per Share (USD) (TTM)
0.17
Market Cap (m USD)
743.946
Shares Outstanding (m)
70.051
Price/Sales (TTM)
10.64
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+0.11%
% Price Change
+0.41%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
Address
1 World Trade Center
47th Floor, Suite J
New York, NY 10007
United States
Phone
1-646-975-2500
Show More